4.5 Article

Coverage and Effectiveness of Kyasanur Forest Disease (KFD) Vaccine in Karnataka, South India, 2005-10

Journal

PLOS NEGLECTED TROPICAL DISEASES
Volume 7, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pntd.0002025

Keywords

-

Ask authors/readers for more resources

Background: Kyasanur forest disease (KFD), a tick-borne viral disease with hemorrhagic manifestations, is localised in five districts of Karnataka state, India. Annual rounds of vaccination using formalin inactivated tissue-culture vaccine have been conducted in the region since 1990. Two doses of vaccine are administered to individuals aged 7-65 years at an interval of one month followed by periodic boosters after 6-9 months. In spite of high effectiveness of the vaccine reported in earlier studies, KFD cases among vaccinated individuals have been recently reported. We analysed KFD vaccination and case surveillance data from 2005 to 2010. Methodology/Principal Findings: We calculated KFD incidence among vaccinated and unvaccinated populations and computed the relative risk and vaccine effectiveness. During 2005-2010, a total of 343,256 individuals were eligible for KFD vaccination (details of vaccination for 2008 were not available). Of these, 52% did not receive any vaccine while 36% had received two doses and a booster. Of the 168 laboratory-confirmed KFD cases reported during this 5-year period, 134 (80%) were unvaccinated, nine each had received one and two doses respectively while 16 had received a booster during the pre-transmission season. The relative risks of disease following one, two and booster doses of vaccine were 1.06 (95% CI = 0.542.1), 0.38 (95% CI = 0.19-0.74) and 0.17 (95% CI = 0.10-0.29) respectively. The effectiveness of the vaccine was 62.4% (95% CI = 26.1-80.8) among those who received two doses and 82.9% (95% CI = 71.3-89.8) for those who received two doses followed by a booster dose as compared to the unvaccinated individuals. Conclusions: Coverage of KFD vaccine in the study area was low. Observed effectiveness of the KFD vaccine was lower as compared to the earlier reports, especially after a single dose administration. Systematic efforts are needed to increase the vaccine coverage and identify the reasons for lower effectiveness of the vaccine in the region.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Burden of Dengue with Related Entomological and Climatic Characteristics in Surat City, Gujarat, India, 2011-2016: An Analysis of Surveillance Data

Viral R. Bajwala, Denny John, Daniel Rajasekar, Alex Eapen, Manoj V. Murhekar

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Article Public, Environmental & Occupational Health

SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey

Manoj Murhekar, Tarun Bhatnagar, Sriram Selvaraju, V Saravanakumar, Jeromie Wesley Vivian Thangaraj, Naman Shah, Muthusamy Santhosh Kumar, Kiran Rade, R. Sabarinathan, Smita Asthana, Rakesh Balachandar, Sampada Dipak Bangar, Avi Kumar Bansal, Jyothi Bhat, Vishal Chopra, Dasarathi Das, Alok Kumar Deb, Kangjam Rekha Devi, Gaurav Raj Dwivedi, S. Muhammad Salim Khan, C. P. Girish Kumar, M. Sunil Kumar, Avula Laxmaiah, Major Madhukar, Amarendra Mahapatra, Suman Sundar Mohanty, Chethana Rangaraju, Alka Turuk, Dinesh Kumar Baradwaj, Ashrafjit S. Chahal, Falguni Debnath, Inaamul Haq, Arshad Kalliath, Srikanta Kanungo, Jaya Singh Kshatri, G. G. J. Naga Lakshmi, Anindya Mitra, A. R. Nirmala, Ganta Venkata Prasad, Mariya Amin Qurieshi, Seema Sahay, Ramesh Kumar Sangwan, Krithikaa Sekar, Vijay Kumar Shukla, Prashant Kumar Singh, Pushpendra Singh, Rajeev Singh, Dantuluri Sheethal Varma, Ankit Viramgami, Samiran Panda, D. C. S. Reddy, Balram Bhargava

Summary: The seroprevalence of SARS-CoV-2 infection in individuals aged 10 years or older in India was 6.6%, with a higher prevalence of 7.1% in adults, and the highest prevalence seen in urban slum areas.

LANCET GLOBAL HEALTH (2021)

Article Public, Environmental & Occupational Health

Secular trends of grossly underreported snakebite burden in India, 2009-2018: analysis of data from India's National Health Profile

Polani Rubeshkumar, Manikandanesan Sakthivel, Vettrichelvan Venkatasamy, Manickam Ponnaiah, Manoj Murhekar

Summary: According to the National Health Profile data from 2009 to 2018, the incidence of snakebites in India ranged from 89 to 141 per million population, with an annual increase of 3%. The incidence was higher among males compared to females, while the case fatality rate showed a declining trend each year.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2021)

Article Multidisciplinary Sciences

Effect of BCG vaccination on proinflammatory responses in elderly individuals

Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Anuradha Rajamanickam, Shrinivasa B. Marinaik, Arul Nancy, Srinivasan Padmanaban, Nabila Akbar, Manoj Murhekar, Subash Babu

Summary: The study found that BCG vaccination reduced levels of various cytokines and chemokines in healthy elderly individuals, leading to decreased inflammation. This suggests the potential utility of BCG vaccination in modulating inflammatory responses and its application in COVID-19.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

COVID-19 testing, timeliness and positivity from ICMR's laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021

Manickam Ponnaiah, Rizwan Suliankatchi Abdulkader, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, Ramasamy Sabarinathan, Saravanakumar Velusamy, Yogesh Sabde, Harpreet Singh, Manoj Vasanth Murhekar

Summary: The Indian Council of Medical Research established a nationwide laboratory network to diagnose and monitor the COVID-19 pandemic. The analysis included 176 million individuals and 188 million tests, revealing an overall incidence of COVID-19 of 0.8% and ten states accounting for 75.6% of the total cases. The laboratory network's rapid scaling enabled daily testing to increase from 40,000 initially to nearly one million by March 2021, with acceptable timeliness between surveillance activities indicating good responsiveness of the system.

PLOS ONE (2021)

Article Medicine, General & Internal

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study

Manoj V. Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, V. Saravanakumar, Muthusamy Santhosh Kumar, Sriram Selvaraju, Kiran Rade, C. P. Girish Kumar, R. Sabarinathan, Smita Asthana, Rakesh Balachandar, Sampada Dipak Bangar, Avi Kumar Bansal, Jyothi Bhat, Debjit Chakraborty, Vishal Chopra, Dasarathi Das, Kangjam Rekha Devi, Gaurav Raj Dwivedi, Agam Jain, S. Muhammad Salim Khan, M. Sunil Kumar, Avula Laxmaiah, Major Madhukar, Amarendra Mahapatra, Talluri Ramesh, Chethana Rangaraju, Jyotirmayee Turuk, Suresh Yadav, Balram Bhargava

Summary: The fourth nationwide serosurvey conducted in India between June and July 2021 showed that over two-thirds of individuals aged 6 years and above in the general population and 85% of healthcare workers had antibodies against SARS-CoV-2. With one-third of the population still seronegative, accelerating COVID-19 vaccination coverage among adults and maintaining non-pharmaceutical interventions is necessary.

PLOS MEDICINE (2021)

Article Public, Environmental & Occupational Health

Shellfish poisoning outbreaks in Cuddalore District, Tamil Nadu, India

Anoop Velayudhan, Janardhan Nayak, Manoj Murhekar, Tanzin Dikid, Samir Sodha

Summary: Two suspected shellfish poisoning outbreaks in Cuddalore District, Tamil Nadu, India in January and April 2015 resulted in symptoms of dizziness and vomiting, with no detection of shellfish toxins. Case-control studies showed a significant association between illness and clam consumption, with no evidence of bacterial contamination in stool samples. Coordination between epidemiologists, marine biologists, and food safety officers led to timely containment of the outbreaks.

INDIAN JOURNAL OF PUBLIC HEALTH (2021)

Article Ophthalmology

Prediction of probability of rubella based on eye outcomes (PORBEO Nomogram)-a cross-sectional sentinel surveillance of 1134 infants

Parul Chawla Gupta, Praveen Kumar-M, Jagat Ram, Sanjay Verma, Ravinder Kaur Sachdeva, Kuldeep Singh, Ashish Bavdekar, Sanjay Shah, Mahantesh Sangappa, Krishna R. Murthy, Sridhar Santhanam, Deepa John, Devika Shanmugasundaram, R. Sabrinathan, Manoj Murhekar

Summary: This study developed a prediction nomogram to assess the probability of an infant being at risk for congenital rubella based on ophthalmological findings and demographics. The results showed that infants at risk had higher odds of cataract, retinopathy, glaucoma, microcornea, and younger age at presentation compared to those not at risk. The nomogram could be used for community-based utilization to prioritize attention to high-risk children and prevent loss to follow-up.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)

Article Immunology

National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance

Muthusamy Santhosh Kumar, Tarun Bhatnagar, Ponnaiah Manickam, V. Saravana Kumar, Kiran Rade, Naman Shah, Shashi Kant, Giridhara R. Babu, Sanjay Zodpey, C. P. Girish Kumar, Jeromie Wesley Vivian Thangaraj, Pranab Chatterjee, Suman Kanungo, Ravindra Mohan Pandey, Manoj Murhekar, Sujeet K. Singh, Swarup Sarkar, J. P. Muliyil, Raman R. Gangakhedkar, D. C. S. Reddy

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Immunology

Exploration of population ecological factors related to the spatial heterogeneity of dengue fever cases diagnosed through a national network of laboratories in India, 2017

Vasna Joshua, Kanagasabai Kaliaperumal, Kirubakaran Bajji Krishnamurthy, Ravi Muthusamy, Ramachandran Venkatachalam, Kethara A. Gowri, Vishal C. Shete, Sabarinathan Ramasamy, Nivedita Gupta, Manoj Vasant Murhekar

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Immunology

Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach

Sandip Mandal, Tarun Bhatnagar, Nimalan Arinaminpathy, Anup Agarwal, Amartya Chowdhury, Manoj Murhekar, Raman R. Gangakhedkar, Swarup Sarkar

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Immunology

Strategic planning to augment the testing capacity for COVID-19 in India

Nivedita Gupta, Tarun Bhatnagar, Kiran Rade, Manoj Murhekar, Raman R. Gangakhedkar, Anu Nagar

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Immunology

Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020

Nivedita Gupta, Ira Praharaj, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, Sidhartha Giri, Himanshu Chauhan, Sanket Kulkarni, Manoj Murhekar, Sujeet Singh, Raman R. Gangakhedkar, Balram Bhargava

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Immunology

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use

Tarun Bhatnagar, Manoj V. Murhekar, Manish Soneja, Nivedita Gupta, Sidhartha Giri, Naveet Wig, Raman Gangakhedkar

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Infectious Diseases

Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey

Muthusamy Santhosh Kumar, Pattabi Kamaraj, Siraj Ahmed Khan, Ramesh Reddy Allam, Pradip Barde, Bhagirathi Dwibedi, Suman Kanungo, Uday Mohan, Suman Sundar Mohanty, Subarna Roy, Vivek Sagar, Deepali Savargaonkar, Babasaheb Tandale, Roshan Kamal Topno, Chethrapilly P. Girish Kumar, Ramasamy Sabarinathan, Velusamy Saravana Kumar, Sailaja Bitragunta, Gagandeep Singh Grover, Pinnaka V. M. Lakshmi, Chandra Mauli Mishra, Provash Sadhukhan, Prakash Kumar Sahoo, Shivendra K. Singh, Chander Prakash Yadav, Elangovan Ramya Dinesh, Thiyagarajan Karunakaran, Chinnasamy Govindhasamy, Thomas Daniel Rajasekar, Annadurai Jeyakumar, Arunachalam Suresh, Duraisamy Augustine, Paparaju Ashok Kumar, Rajesh Kumar, Shanta Dutta, Gurudayal S. Toteja, Nivedita Gupta, Hannah E. Clapham, Sanjay M. Mehendale, Manoj Murhekar

Summary: The study found that chikungunya virus transmission was higher in the southern, western, and northern regions of India compared to the eastern and northeastern regions. However, a higher proportion of the population susceptible to CHIKV in the eastern and northeastern regions suggests a vulnerability to outbreaks in the future. The survey findings will be beneficial in identifying target age groups and locations for surveillance and future CHIKV vaccine trials.

LANCET MICROBE (2021)

No Data Available